NFERENCE, INC.

Profile

Company Names

NFERENCE, INC.

Addresses

ONE MAIN STREET, SUITE 400, EAST ARCADE, 4TH FLOOR, CAMBRIDGE, MA 02142

Phone Numbers

781-341-0941

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$12,344,595.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2022-10-21 
$2,744,005.00 
$2,744,005.00 
$0.00 
Equity 
1
2020-03-02 
$9,600,590.00 
$9,600,590.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MURALI 
 
ARAVAMUDAN 
EXECUTIVE OFFICER, DIRECTOR
NFERENCE, INC.   |  ANUMANA, INC.
TIM 
 
BARROWS 
DIRECTOR
PLEXXI INC.   |  AQUTO CORP   |  CONFER TECHNOLOGIES, INC.   |  CLOUDZERO INC.   |  NFERENCE, INC.
ANDREW 
 
DANIELSEN 
DIRECTOR
VAVOTAR LIFE SCIENCES LLC   |  QLARIS BIO, INC.   |  NFERENCE, INC.   |  HUMAN BIOTECH, INC.
HARRIS 
 
FISHMAN 
EXECUTIVE OFFICER
BIDDINGFORGOOD, INC.   |  AFFIRMED NETWORKS, INC.   |  NFERENCE, INC.   |  ANUMANA, INC.
DAVID 
 
GOEL 
DIRECTOR
MATRIX CAPITAL MANAGEMENT FUND L P   |  MATRIX CAPITAL MANAGEMENT FUND II L P   |  MATRIX ENDOWMENT FUND (OVERSEAS) LTD.   |  MATRIX CAPITAL MANAGEMENT FUND (OFFSHORE) LTD   |  MATRIX CAPITAL MANAGEMENT FUND LP   |  MATRIX CAPITAL MANAGEMENT FUND II LP   |  MATRIX CAPITAL MANAGEMENT FUND (OFFSHORE) LTD.   |  NFERENCE, INC.   |  CAMBALT SOLUTIONS, INC.   |  AYURMAYA CAPITAL MANAGEMENT FUND, LP   |  ALTPEP CORP   |  ANUMANA, INC.
JOHN 
 
HALAMKA 
DIRECTOR
NFERENCE, INC.
AGUSTIN 
 
MARQUEZ 
EXECUTIVE OFFICER
NFERENCE, INC.
THOMAS 
 
MCNAUGHTON 
EXECUTIVE OFFICER
BIOSTAGE, INC.   |  NFERENCE, INC.
AJIT 
 
RAJASEKHARAN 
EXECUTIVE OFFICER
NFERENCE, INC.
VENKATARAMANAN 
 
SOUNDARARAJAN 
EXECUTIVE OFFICER
NFERENCE, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-11-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-10-21 
2020-03-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-02 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#